145 related articles for article (PubMed ID: 23337980)
1. Clinical significance of altered S100A2 expression in gastric cancer.
Zhao Y; Zhang TB; Wang Q
Oncol Rep; 2013 Apr; 29(4):1556-62. PubMed ID: 23337980
[TBL] [Abstract][Full Text] [Related]
2. Loss of Reprimo and S100A2 expression in human gastric adenocarcinoma.
Luo J; Zhu Y; Yang G; Gong L; Wang B; Liu H
Diagn Cytopathol; 2011 Oct; 39(10):752-7. PubMed ID: 20949468
[TBL] [Abstract][Full Text] [Related]
3. Over-expression of S100A2 in pancreatic cancer correlates with progression and poor prognosis.
Ohuchida K; Mizumoto K; Miyasaka Y; Yu J; Cui L; Yamaguchi H; Toma H; Takahata S; Sato N; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
J Pathol; 2007 Nov; 213(3):275-82. PubMed ID: 17940995
[TBL] [Abstract][Full Text] [Related]
4. The role of Reg IV gene and its encoding product in gastric carcinogenesis.
Zheng HC; Xu XY; Yu M; Takahashi H; Masuda S; Takano Y
Hum Pathol; 2010 Jan; 41(1):59-69. PubMed ID: 19740514
[TBL] [Abstract][Full Text] [Related]
5. Expression of calcium-binding proteins S100A2 and S100A4 in Barrett's adenocarcinomas.
Lee OJ; Hong SM; Razvi MH; Peng D; Powell SM; Smoklin M; Moskaluk CA; El-Rifai W
Neoplasia; 2006 Oct; 8(10):843-50. PubMed ID: 17032501
[TBL] [Abstract][Full Text] [Related]
6. S100 calcium-binding protein A4 is a novel independent prognostic factor for the poor prognosis of gastric carcinomas.
Zhao Y; Zhang T; Wang Q
Oncol Rep; 2013 Jul; 30(1):111-8. PubMed ID: 23612849
[TBL] [Abstract][Full Text] [Related]
7. Nuclear or cytoplasmic localization of Bag-1 distinctly correlates with pathologic behavior and outcome of gastric carcinomas.
Zheng HC; Xu XY; Xing YN; Wei ZL; Takahashi H; Masuda S; Takano Y
Hum Pathol; 2010 May; 41(5):724-36. PubMed ID: 20096920
[TBL] [Abstract][Full Text] [Related]
8. Difference of p53AIP1 mRNA expression in gastric mucosa between patients with gastric cancer and chronic gastritis infected with Helicobacter pylori.
Sawaya M; Yoshimura T; Shimoyama T; Munakata A; Fukuda S
J Clin Gastroenterol; 2008 Apr; 42(4):351-5. PubMed ID: 18277906
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of S100A2 and S100A4 in lung adenocarcinomas: clinicopathological significance, relationship to p53 and identification of their target genes.
Matsubara D; Niki T; Ishikawa S; Goto A; Ohara E; Yokomizo T; Heizmann CW; Aburatani H; Moriyama S; Moriyama H; Nishimura Y; Funata N; Fukayama M
Cancer Sci; 2005 Dec; 96(12):844-57. PubMed ID: 16367903
[TBL] [Abstract][Full Text] [Related]
10. [Down-regulation of caveolin-1 in gastric carcinoma and its clinical biological significance].
Gao X; Sun Y; Huang L; Chen XY; Zhang KL; Kong QY; Liu J; Li H
Ai Zheng; 2005 Mar; 24(3):311-6. PubMed ID: 15757532
[TBL] [Abstract][Full Text] [Related]
11. COL4A3 expression correlates with pathogenesis, pathologic behaviors, and prognosis of gastric carcinomas.
Nie XC; Wang JP; Zhu W; Xu XY; Xing YN; Yu M; Liu YP; Takano Y; Zheng HC
Hum Pathol; 2013 Jan; 44(1):77-86. PubMed ID: 22939955
[TBL] [Abstract][Full Text] [Related]
12. Distinctive patterns of gene expression in premalignant gastric mucosa and gastric cancer.
Boussioutas A; Li H; Liu J; Waring P; Lade S; Holloway AJ; Taupin D; Gorringe K; Haviv I; Desmond PV; Bowtell DD
Cancer Res; 2003 May; 63(10):2569-77. PubMed ID: 12750281
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of S100A2 in lymph node metastases of head and neck cancer.
Zhang X; Hunt JL; Shin DM; Chen ZG
Head Neck; 2007 Mar; 29(3):236-43. PubMed ID: 17123307
[TBL] [Abstract][Full Text] [Related]
14. Arp2/3 overexpression contributed to pathogenesis, growth and invasion of gastric carcinoma.
Zheng HC; Zheng YS; Li XH; Takahashi H; Hara T; Masuda S; Yang XH; Guan YF; Takano Y
Anticancer Res; 2008; 28(4B):2225-32. PubMed ID: 18751399
[TBL] [Abstract][Full Text] [Related]
15. Promoter hyper-methylation of calcium binding proteins S100A6 and S100A2 in human prostate cancer.
Rehman I; Cross SS; Catto JW; Leiblich A; Mukherjee A; Azzouzi AR; Leung HY; Hamdy FC
Prostate; 2005 Dec; 65(4):322-30. PubMed ID: 16015609
[TBL] [Abstract][Full Text] [Related]
16. Pathological disorders of the gastric mucosa surrounding carcinomas and primary lymphomas.
Arista-Nasr J; Jiménez-Rosas F; Uribe-Uribe N; Herrera-Goepfert R; Lazos-Ochoa M
Am J Gastroenterol; 2001 Jun; 96(6):1746-50. PubMed ID: 11419824
[TBL] [Abstract][Full Text] [Related]
17. [Expression of syndecan-1 at different stages in the course of gastric carcinoma and its significance].
Xi YX; Song X; Chen J; Chen HX; Peng TS; Lin HL; Chen MH
Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):193-6. PubMed ID: 17649635
[TBL] [Abstract][Full Text] [Related]
18. Clinical Significance of Myeloid Zinc Finger 1 Expression in the Progression of Gastric Tumourigenesis.
Li GQ; He Q; Yang L; Wang SB; Yu DD; He YQ; Hu J; Pan YM; Wu Y
Cell Physiol Biochem; 2017; 44(3):1242-1250. PubMed ID: 29179204
[TBL] [Abstract][Full Text] [Related]
19. Upregulated expression of S100A6 in human gastric cancer.
Yang YQ; Zhang LJ; Dong H; Jiang CL; Zhu ZG; Wu JX; Wu YL; Han JS; Xiao HS; Gao HJ; Zhang QH
J Dig Dis; 2007 Nov; 8(4):186-93. PubMed ID: 17970874
[TBL] [Abstract][Full Text] [Related]
20. Expression of metallothionein II in intestinal metaplasia, dysplasia, and gastric cancer.
Ebert MP; Günther T; Hoffmann J; Yu J; Miehlke S; Schulz HU; Roessner A; Korc M; Malfertheiner P
Cancer Res; 2000 Apr; 60(7):1995-2001. PubMed ID: 10766190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
